Nomura Asset Management International’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207M Buy
821,326
+113,956
+16% +$24.5M 0.31% 42
2026
Q1
$154M Sell
707,370
-27,275
-4% -$6.05M 0.26% 64
2025
Q4
$168M Buy
+734,645
New +$167M 0.25% 66

Other funds holding ABBV

Nomura Asset Management International's ABBV Position: Q2 2026 in Review

Nomura Asset Management International increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $24.5M and bringing the position to 821,326 shares worth $207M. The position accounts for 0.31% of the portfolio, ranked #42.

Nomura Asset Management International first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Nomura Asset Management International held 821,326 shares of AbbVie worth $207M as of Q2 2026.
  • Nomura Asset Management International bought 113,956 AbbVie shares in Q2 2026, an estimated $24.5M.
  • AbbVie made up 0.31% of Nomura Asset Management International's portfolio in Q2 2026, its #42 holding.
  • Nomura Asset Management International first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.